MA24345A1 - Analogues de vitamines d3 - Google Patents

Analogues de vitamines d3

Info

Publication number
MA24345A1
MA24345A1 MA24629A MA24629A MA24345A1 MA 24345 A1 MA24345 A1 MA 24345A1 MA 24629 A MA24629 A MA 24629A MA 24629 A MA24629 A MA 24629A MA 24345 A1 MA24345 A1 MA 24345A1
Authority
MA
Morocco
Prior art keywords
vitamin analogs
analogs
vitamin
Prior art date
Application number
MA24629A
Other languages
English (en)
Inventor
Radoje Uskokovic Milan
Michael Hennessy Bernard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA24345A1 publication Critical patent/MA24345A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA24629A 1996-05-23 1997-05-21 Analogues de vitamines d3 MA24345A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (1)

Publication Number Publication Date
MA24345A1 true MA24345A1 (fr) 1998-07-01

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24629A MA24345A1 (fr) 1996-05-23 1997-05-21 Analogues de vitamines d3

Country Status (30)

Country Link
US (1) US5888994A (fr)
EP (1) EP0808831B1 (fr)
JP (1) JP2858571B2 (fr)
KR (1) KR100237523B1 (fr)
CN (1) CN1081184C (fr)
AR (1) AR007240A1 (fr)
AT (1) ATE195514T1 (fr)
AU (1) AU720098B2 (fr)
BR (1) BR9703373A (fr)
CA (1) CA2204478C (fr)
CO (1) CO4840512A1 (fr)
CZ (1) CZ157997A3 (fr)
DE (1) DE69702812T2 (fr)
DK (1) DK0808831T3 (fr)
ES (1) ES2150719T3 (fr)
GR (1) GR3034832T3 (fr)
HR (1) HRP970274A2 (fr)
HU (1) HUP9700927A3 (fr)
IL (1) IL120842A0 (fr)
MA (1) MA24345A1 (fr)
NO (1) NO971934L (fr)
NZ (1) NZ314838A (fr)
PL (1) PL320131A1 (fr)
PT (1) PT808831E (fr)
SG (1) SG50831A1 (fr)
TR (1) TR199700418A3 (fr)
TW (1) TW374762B (fr)
UY (1) UY24563A1 (fr)
YU (1) YU19997A (fr)
ZA (1) ZA974334B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
WO1998051678A1 (fr) * 1997-05-16 1998-11-19 Women & Infants Hospital COMPOSES DE VITAMINE D3 A ETHER CYCLIQUE ET COMPOSES DE 1α(OH)3-EPI-VITAMINE D3, ET UTILISATION DESDITS COMPOSES
DE69834109T2 (de) * 1997-05-16 2007-04-19 Woman & Infants Hospital 3-epi-vitamin d2 verbindungen und ihre anwendungen
WO1999012894A1 (fr) * 1997-09-08 1999-03-18 F. Hoffmann-La Roche Ag Analogues de vitamine d3 de 1,3-dihydroxy-20,20-dialkyle
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
EP1812011A1 (fr) 2004-11-12 2007-08-01 Bioxell S.p.a. Emploi combiné de dérivés de vitamine d et d'agents antiproliférants pour le traitement de cancers de la vessie
CA2882048C (fr) 2006-02-03 2020-03-24 Opko Renal, Llc Traitement de l'insuffisance et de la deficience de vitamine d avec de la 25-hydroxyvitamine d2 et de la 25-hydroxyvitamine d3
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
WO2009047644A2 (fr) 2007-04-25 2009-04-16 Cytochroma Inc. Procédé de traitement d'une insuffisance et d'une carence en vitamine d
ES2401205T3 (es) 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
CN103037902A (zh) 2010-03-29 2013-04-10 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
EP4596045A3 (fr) 2016-03-28 2025-10-15 EirGen Pharma Ltd. Procédés de traitement de la vitamine d

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
CA2096105A1 (fr) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Analogues fluores de vitamine d3
TW267161B (fr) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
CO4840512A1 (es) 1999-09-27
IL120842A0 (en) 1997-09-30
ES2150719T3 (es) 2000-12-01
HRP970274A2 (en) 1998-04-30
CN1081184C (zh) 2002-03-20
AU720098B2 (en) 2000-05-25
HUP9700927A3 (en) 1999-07-28
CZ157997A3 (en) 1997-12-17
HUP9700927A2 (hu) 1998-01-28
DE69702812D1 (de) 2000-09-21
ZA974334B (en) 1997-11-24
KR970074763A (ko) 1997-12-10
CN1169425A (zh) 1998-01-07
MX9703776A (es) 1998-06-30
TR199700418A2 (xx) 1997-12-21
TR199700418A3 (tr) 1997-12-21
AR007240A1 (es) 1999-10-27
BR9703373A (pt) 1998-09-15
AU2357297A (en) 1997-11-27
DK0808831T3 (da) 2001-01-02
NO971934D0 (no) 1997-04-25
PL320131A1 (en) 1997-11-24
HU9700927D0 (en) 1997-07-28
ATE195514T1 (de) 2000-09-15
EP0808831A3 (fr) 1999-02-03
UY24563A1 (es) 2000-12-29
DE69702812T2 (de) 2001-01-25
NZ314838A (en) 1998-01-26
EP0808831B1 (fr) 2000-08-16
SG50831A1 (en) 1998-07-20
TW374762B (en) 1999-11-21
CA2204478A1 (fr) 1997-11-23
JPH1045712A (ja) 1998-02-17
KR100237523B1 (ko) 2000-01-15
US5888994A (en) 1999-03-30
GR3034832T3 (en) 2001-02-28
JP2858571B2 (ja) 1999-02-17
EP0808831A2 (fr) 1997-11-26
NO971934L (no) 1997-11-24
PT808831E (pt) 2000-12-29
YU19997A (sh) 1999-07-28
CA2204478C (fr) 2006-11-21

Similar Documents

Publication Publication Date Title
MA24251A1 (fr) Analogues de vitamine d3
FR2785284B1 (fr) Analogues de la vitamine d
FI960303L (fi) D-vitamiinianalogeja
FR2801305B1 (fr) Analogues de la vitamine d
EP0996458A4 (fr) Analogues de sandramycine
FI956108A7 (fi) Uudet D-vitamiinianalogit
NO990164D0 (no) Illudinanaloger nyttige som antitumormidler
BR9703373A (pt) Análogos de vitamina d3 fluorados
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
MA26808A1 (fr) Analogues de la vitamine d3.
FR2801307B1 (fr) Analogues de la vitamine d
FI935092L (fi) D3-vitaminanaloger
MA24250A1 (fr) Analogues de vitamine d3
ZA974332B (en) Fluorinated vitamin D3 analogs.
SI1023263T1 (en) Novel vitamin d analogues